NeuroSense Therapeutics Ltd. Current Assets
NeuroSense Therapeutics Ltd. (NRSN) had Current Assets of $778.00 thousand as of 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-03-31
- 2025-12-31: Assets, Current $778.00K.
- 2025-06-30: Assets, Current $1.56M.
- 2024-12-31: Assets, Current $4.40M.
- 2024-06-30: Assets, Current $1.62M.
| Period end | Assets, Current |
|---|---|
| 2025-12-31 | $778.00K 20-F · filed 2026-03-31 |
| 2025-06-30 | $1.56M 6-K · filed 2025-08-01 |
| 2024-12-31 | $4.40M 20-F · filed 2026-03-31 |
| 2024-06-30 | $1.62M 6-K · filed 2024-09-30 |
| 2023-12-31 | $2.92M 20-F · filed 2025-04-07 |
| 2022-12-31 | $7.38M 6-K · filed 2024-06-17 |